+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

North America Immunochemistry Market to 2027 - Regional Analysis and Forecasts By Application; Product; End User, and Country

  • ID: 4987823
  • Report
  • January 2020
  • Region: North America
  • 194 pages
  • The Insight Partners
UP TO OFF
until Sep 30th 2020
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Abcam Plc
  • Agilent Technologies,
  • Bio SB
  • Danaher
  • F. Hoffmann-La Roche Ltd.
  • Merck KGaA
  • MORE
The North America immunochemistry market is expected to reach US$ 1,536.87 Mn in 2027 from US$ 806.34 Mn in 2018. The market is anticipated to grow with a CAGR of 7.6 % from 2019-2027.

The growth of the immunochemistry market is primarily attributed to the rising incidences of chronic and infectious diseases and the increasing geriatric population. However, the limitations associated with immunohistochemistry is likely to have a negative impact on market growth. On the other hand, development opportunities in the region are likely to have a positive impact on the growth of the North America immunochemistry market in the coming years.

The growing elderly population is the primary cause of chronic diseases. Aging is a complex process influenced by genetic variables as well as environmental factors. Thus, people with the age of 75 years and above high blood pressure are the common risk factor for cardiovascular diseases, including blood-associated cancer. Management of these disorders in older patients must often be weighed in a setting of decreased physiological reserves and concurrent illnesses. According to the United Nation’s World Population Ageing 2017 report, in 2017, there were 962 million people across the world who were aged 60 years or over, and the number is expected to reach nearly 2.1 billion by 2050. Also, as per the analysis of the US Census Bureau the number of Americans above the age of 65 and older is anticipated to grow more than double from 46 million in 2016 to above 98 million by 2060, and the 65-and-older age group’s share in the world’s population will produce around 24% from 15 percent.

According to the National Council on Aging, approximately 80% of adults suffer from at least one chronic disease, whereas 77% of aged people suffer from two. These chronic diseases majorly comprise cancer, heart disease, diabetes, and stroke. Immunohistochemistry techniques help in the quantification and diagnosis of these diseases accurately and reliably. The rising geriatric population in the world is thus likely to grow the immunohistochemistry market in the forecast period.

In 2018, the diagnostics segment accounted for the largest market share in the North America immunohistochemistry market by the application. The growing benefits of immunohistochemistry have prolonged technology usage to diagnose several chronic diseases. The application of the molecular diagnostics has allowed to treat the patients as per their genetic make-up also diagnosis through immunohistochemistry that helps to increase the use in precision medicine. Even the cost-effective nature of the immunochemistry is driving significant growth across the region.

In 2018, the antibodies held the largest market share of the immunochemistry market by the product that also anticipated to dominate the market in 2027. Moreover, the reagent segment is anticipated to register the highest CAGR during the forecast period in the market, since they form an essential component of any reaction and can be chosen as per the result to be obtained.

In 2018, the hospital & diagnostic laboratories segment held the most significant market share of the immunochemistry market, by the end-user. This segment is also anticipated to dominate the market in 2027. Besides, the segment is also expected to grow at the fastest rate during the coming years due to the rise in the prevalence of infectious diseases, cancer, and autoimmune disorders.

Some of the major primary and secondary sources for immunochemistry included in the report are, Federation of AIDS Organisations (AFAO), American Heart Association (AHA), HIV and AIDS organization (AVERT), Centers for Disease Control and Prevention (CDC), Centers for Diabetes and Endocrinology (CDE), Food and Drug Administration (FDA) and others.

Reasons to Buy
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America immunochemistry market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the North America immunochemistry market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth regional market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Abcam Plc
  • Agilent Technologies,
  • Bio SB
  • Danaher
  • F. Hoffmann-La Roche Ltd.
  • Merck KGaA
  • MORE
1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance

2. North America Immunochemistry Market- Key Takeaways

3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. North America Immunochemistry Market - Market Landscape
4.1 Overview
4.2 Market Segmentation
4.2.1 North America Immunochemistry Market - By Product
4.2.2 North America Immunochemistry Market - By Application
4.2.3 North America Immunochemistry Market - By End User
4.2.4 North America Immunochemistry Market - By Country
4.3 PEST Analysis

5. North America Immunochemistry Market - Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Rising Incidences of Chronic and Infectious Diseases
5.1.2 Increasing Geriatric Population
5.2 Key Market Restraints
5.2.1 Limitations Associated with Immunohistochemistry
5.3 Key Market Opportunities
5.3.1 Development Opportunities in Emerging Countries
5.4 Future Trends
5.4.1 Increasing Acceptance of Automation in Immunohistochemistry
5.5 Impact Analysis

6. Immunochemistry Market - North America Analysis
6.1 North America Immunochemistry Market Revenue Forecasts And Analysis
6.2 Performance of Key Players

7. North America Immunochemistry Market Analysis - By Application
7.1 Overview
7.2 North America Immunochemistry Market, By Application, 2018 & 2027 (%)
7.3 North America Immunochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)
7.4 Diagnostics
7.4.1 Overview
7.4.2 North America Diagnostics Market Revenue and Forecast to 2027 (US$ Mn)
7.4.3 Cancer
7.4.3.1 Overview
7.4.3.2 North America Cancer Market Revenue and Forecast to 2027 (US$ Mn)
7.4.4 Infectious Diseases
7.4.4.1 Overview
7.4.4.2 North America Infectious Diseases Market Revenue and Forecast to 2027 (US$ Mn)
7.4.5 Autoimmune Diseases
7.4.5.1 Overview
7.4.5.2 North America Autoimmune Diseases Market Revenue and Forecast to 2027 (US$ Mn)
7.4.6 Nephrological Diseases
7.4.6.1 Overview
7.4.6.2 North America Nephrological Diseases Market Revenue and Forecast to 2027 (US$ Mn)
7.5 Drug Testing
7.5.1 Overview
7.5.2 North America Drug Testing Market Revenue and Forecast to 2027 (US$ Mn)

8. North America Immunochemistry Market Analysis - By Product
8.1 Overview
8.2 North America Immunochemistry Market, By Product, 2018 & 2027 (%)
8.3 North America Immunochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)
8.3.1 North America Antibodies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.3.2 North America Equipment Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.3.2.1 North America Reagents Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.4 Antibodies Market
8.4.1 Overview
8.4.2 North America Antibodies Market Revenue and Forecasts to 2027 (US$ Mn)
8.4.3 Primary Antibodies
8.4.3.1 Overview
8.4.3.2 North America Primary Antibodies Market Revenue and Forecasts to 2027 (US$ Mn)
8.4.4 Secondary Antibodies
8.4.4.1 Overview
8.4.4.2 North America Secondary Antibodies Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 Equipment
8.5.1 Overview
8.5.2 North America Equipment Market Revenue and Forecasts to 2027 (US$ Mn)
8.5.3 Slide Staining Systems
8.5.3.1 Overview
8.5.3.2 North America Slide Staining Systems Market Revenue and Forecasts to 2027 (US$ Mn)
8.5.4 Tissue Microarrays
8.5.4.1 Overview
8.5.4.2 North America Tissue Microarrays Market Revenue and Forecasts to 2027 (US$ Mn)
8.5.5 Slide Scanners
8.5.5.1 Overview
8.5.5.2 North America Slide Scanners Market Revenue and Forecasts to 2027 (US$ Mn)
8.5.6 Other Equipment
8.5.6.1 Overview
8.5.6.2 North America Other Equipment Market Revenue and Forecasts to 2027 (US$ Mn)
8.6 Reagents
8.6.1 Overview
8.6.2 North America Reagents Market Revenue and Forecasts to 2027 (US$ Mn)
8.6.3 Histological Stains
8.6.3.1 Overview
8.6.3.2 North America Histological Stains Market Revenue and Forecasts to 2027 (US$ Mn)
8.6.4 Blocking & Fixation Reagents
8.6.4.1 Overview
8.6.4.2 North America Blocking & Fixation Reagents Market Revenue and Forecasts to 2027 (US$ Mn)
8.6.5 Chromogenic Substrates
8.6.5.1 Overview
8.6.5.2 North America Chromogenic Substrates Market Revenue and Forecasts to 2027 (US$ Mn)
8.6.6 Stabilizers
8.6.6.1 Overview
8.6.6.2 North America Stabilizers Market Revenue and Forecasts to 2027 (US$ Mn)
8.6.7 Proteolytic Enzymes
8.6.7.1 Overview
8.6.7.2 North America Proteolytic Enzymes Market Revenue and Forecasts to 2027 (US$ Mn)
8.6.8 Solvents
8.6.8.1 Overview
8.6.8.2 North America Solvents Market Revenue and Forecasts to 2027 (US$ Mn)
8.7 Kits
8.7.1 Overview
8.7.2 North America Kits Market Revenue and Forecasts to 2027 (US$ Mn)

9. North America Immunochemistry Market Analysis - By End User
9.1 Overview
9.2 North America Immunochemistry Market, By End User, 2018 & 2027 (%)
9.3 North America Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.4 Hospital & Diagnostic Laboratories
9.4.1 Overview
9.4.2 North America Hospital & Diagnostic Laboratories Market Revenue and Forecasts to 2027 (US$ Mn)
9.5 Research Institutes
9.5.1 Overview
9.5.2 North America Research Institutes Market Revenue and Forecasts to 2027 (US$ Mn)
9.6 Others End Users
9.6.1 Overview
9.6.2 North America Others Market Revenue and Forecasts to 2027 (US$ Mn)

10. North America Immunochemistry Market Revenue and Forecasts To 2027
10.1 Overview
10.1.1 North America Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.2 North America Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)
10.1.2.1 North America Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.1.3 North America Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.1.3.1 North America Antibodies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.1.3.2 North America Equipment Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.1.3.3 North America Reagents Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.1.4 North America Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.1.5 North America Immunohistochemistry Market Revenue and Forecasts to 2027, By Country (%)
10.1.6 US Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.6.1 US Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.6.2 US Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)
10.1.6.2.1 US Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.1.6.3 US Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.1.6.3.1 US Antibodies Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.1.6.3.2 US Equipment Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.1.6.3.3 US Reagents Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.1.6.4 US Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.1.7 Canada Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.7.1 Canada Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.7.2 Canada Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)
10.1.7.2.1 Canada Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.1.7.3 Canada Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.1.7.3.1 Canada Antibodies Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.1.7.3.2 Canada Equipment Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.1.7.3.3 Canada Reagents Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.1.7.4 Canada Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.1.8 Mexico Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.8.1 Mexico Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.8.2 Mexico Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)
10.1.8.2.1 Mexico Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.1.8.3 Mexico Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.1.8.3.1 Mexico Antibodies Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.1.8.3.2 Mexico Equipment Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.1.8.3.3 Mexico Reagents Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.1.8.4 Mexico Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)

11. Immunochemistry Market - Industry Landscape
11.1 Overview
11.2 Growth Strategies done by the companies in the Market, 2018 (%)
11.3 Organic Developments
11.3.1 Overview
11.4 Inorganic developments
11.4.1 Overview

12. Immunohistochemistry Market-Key Company Profiles
12.1 Bio SB
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Financial Overview
12.1.4 Product portfolio
12.1.5 SWOT ANALYSIS
12.1.6 Key Developments
12.2 Cell Signaling Technology, Inc.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Financial Overview
12.2.4 Product portfolio
12.2.5 SWOT ANALYSIS
12.2.6 Key Developments
12.3 F. Hoffmann-La Roche Ltd.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Financial Overview
12.3.4 Product Portfolio
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Merck KGaA
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Financial Overview
12.4.4 Product Portfolio
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 PerkinElmer, Inc.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Financial Overview
12.5.4 Product Portfolio
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Thermo Fisher Scientific, Inc.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Financial Overview
12.6.4 Product Portfolio
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Abcam Plc.
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Financial Overview
12.7.4 Product Portfolio
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Agilent Technologies, Inc.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Financial Overview
12.8.4 Product Portfolio
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Bio-Rad Laboratories, Inc.
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Financial Information
12.9.4 Product Portfolio
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Danaher
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Financial Information
12.10.4 Product Portfolio
12.10.5 SWOT Analysis
12.10.6 Key Developments

13. Appendix
13.1 About the Publisher
13.2 Glossary Of Terms
13.3 Methodology
13.3.1 Coverage
13.3.2 Secondary Research
13.3.3 Primary Research
Note: Product cover images may vary from those shown
3 of 3
  • PerkinElmer, Inc.
  • Abcam Plc
  • Agilent Technologies,
  • Bio SB
  • Bio-Rad Laboratories, Inc.
  • Cell Signalling Technology, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Danaher
  • Merck KGaA
  • Thermo Fisher Scientific, Inc.
Note: Product cover images may vary from those shown
Adroll
adroll